ECO Animal Health Group plc (AIM:EAH)

Market Cap	59.63M +43.1%
Revenue (ttm)	85.81M +1.4%
Net Income	3.02M +359.0%
EPS	0.04 +352.1%
Shares Out	67.76M
PE Ratio	20.27
Forward PE	28.39
Dividend	n/a
Ex-Dividend Date	n/a

Volume	260,611
Open	88.38
Previous Close	88.60
Day's Range	88.00 - 89.89
52-Week Range	55.56 - 116.90
Beta	-0.01
Analysts	Strong Buy
Price Target	187.20 (+112.73%)
Earnings Date	Jul 17, 2026

About ECO Animal Health Group

ECO Animal Health Group plc, together with its subsidiaries, manufactured and supply animal health products internationally. The company provides Aivlosin, a macrolide antibiotic for the treatment of enteric and respiratory diseases in pigs and poultry. It also offers generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatment and prevention of parasites in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infectio...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1972
• Employees: 200
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: EAH

Financial Performance

In fiscal year 2025, ECO Animal Health Group's revenue was 79.60 million, a decrease of -10.99% compared to the previous year's 89.42 million. Earnings were 1.69 million, an increase of 60.88%.

Analyst Summary

According to 4 analysts, the average rating for EAH stock is "Strong Buy." The 12-month stock price target is 187p, which is an increase of 112.73% from the latest price.

Price Target

187p

(112.73% upside)

Analyst Consensus: Strong Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 10, 2026

Data Sources Report a data error